Hai-long Tang

Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

LncRNA AC021683.2 promotes chemotherapy resistance in acute myeloid leukemia.

LncRNA AC021683.2 promotes chemotherapy resistance in acute myeloid leukemia.

Journal: iScience
Published: October 30, 2024

Causal associations between the gut microbiota and multiple myeloma: a two-sample Mendelian randomization study.

Causal associations between the gut microbiota and multiple myeloma: a two-sample Mendelian randomization study.

Journal: Frontiers in nutrition
Published: March 13, 2024

Efficacy and Safety of Venetoclax-Based Induction Therapy in Acute Myeloid Leukemia

Efficacy and Safety of Venetoclax-Based Induction Therapy in Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 08, 2023

Clinical Characteristics and Prognosis of Systemic Anaplastic Large Cell Lymphoma

Clinical Characteristics and Prognosis of Systemic Anaplastic Large Cell Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 18, 2022

The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects.

The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects.

Journal: Journal of oncology
Published: January 17, 2022

PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer.

PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer.

Journal: Oncogene
Published: September 07, 2021

BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis.

BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis.

Journal: Therapeutic advances in hematology
Published: February 04, 2020

Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis.

Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis.

Journal: OncoTargets and therapy
Published: May 03, 2019

Influence of CD117 Expression on Response of Multiple Myeloma Patients to Chemotherapy

Influence of CD117 Expression on Response of Multiple Myeloma Patients to Chemotherapy

Journal: Zhongguo shi yan xue ye xue za zhi
Published: November 03, 2015

Valproic Acid Represses Autophagy and Enhances the Anti-myeloma Activity of DNA-damaging Drugs

Valproic Acid Represses Autophagy and Enhances the Anti-myeloma Activity of DNA-damaging Drugs

Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 29, 2015

Invasive fungal infection caused by geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review.

Invasive fungal infection caused by geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review.

Journal: International journal of clinical and experimental medicine
Published: June 11, 2015

Inducing effect of chidamide on apoptosis of multiple myeloma cells and its relerance to DNA damage response

Inducing effect of chidamide on apoptosis of multiple myeloma cells and its relerance to DNA damage response

Journal: Zhongguo shi yan xue ye xue za zhi
Published: May 08, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026